Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Tehran, Iran.
Int J Clin Pract. 2024 Mar 9;2024:6638269. doi: 10.1155/2024/6638269. eCollection 2024.
The emergence of antibiotic-resistant strains, the decreased effectiveness of conventional therapies, and the side effects have led researchers to seek a safer, more cost-effective, patient-friendly, and effective method that does not develop antibiotic resistance. With progress in synthetic biology and genetic engineering, genetically engineered microorganisms effective in treatment, prophylaxis, drug delivery, and diagnosis have been developed. The present study reviews the types of genetically engineered bacteria and phages, their impacts on diseases, cancer, and metabolic and inflammatory disorders, the biosynthesis of these modified strains, the route of administration, and their effects on the environment. We conclude that genetically engineered microorganisms can be considered promising candidates for adjunctive treatment of diseases and cancers.
抗生素耐药菌株的出现、常规疗法效果降低以及副作用,促使研究人员寻求一种更安全、更具成本效益、对患者更友好且不易产生耐药性的方法。随着合成生物学和基因工程的进步,已经开发出了在治疗、预防、药物输送和诊断方面有效的基因工程微生物。本研究综述了基因工程细菌和噬菌体的类型、它们对疾病、癌症以及代谢和炎症性疾病的影响、这些改良菌株的生物合成、给药途径以及它们对环境的影响。我们得出结论,基因工程微生物可以被认为是疾病和癌症辅助治疗的有前途的候选者。